Page last updated: 2024-10-31

neostigmine and Metabolic Diseases

neostigmine has been researched along with Metabolic Diseases in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARTIN, GJ1
Bräutigam, HH1
Netter, KJ1
Rietbrock, N1

Other Studies

2 other studies available for neostigmine and Metabolic Diseases

ArticleYear
The action of prostigmine in the nutritional muscular dystrophy of vitamin E deficiency.
    Experimental medicine and surgery, 1946, Volume: 4, Issue:4

    Topics: Humans; Metabolic Diseases; Minerals; Muscular Dystrophies; Neostigmine; Vitamin E; Vitamin E Defici

1946
[Postoperative apnea after suxamethonium].
    Archiv fur Gynakologie, 1966, Volume: 203, Issue:3

    Topics: Adult; Apnea; Bis-Trimethylammonium Compounds; Blood Transfusion; Cholinesterases; Female; Humans; M

1966